Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Rohit Dhall

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Dhall, Rohit

Item TypeName
Concept Double-Blind Method
Academic Article Parkinson's disease severity and use of dopaminergic medications.
Academic Article Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
Academic Article Sex Differences in Clinical Features of Early, Treated Parkinson's Disease.
Academic Article Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial.
Academic Article Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An?Analysis?of?NET-PD LS1.
Academic Article Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.
Academic Article Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.
Academic Article Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.
Academic Article Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial.
Academic Article The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.
Academic Article A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease.
Academic Article Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Academic Article Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study.

Search Criteria
  • Double Blind Method